Vicente LLP Federal and International Cannabis and Psychedelics Law and Policy Update: November 2023
Nov 10, 2023
Federal and international law and policy insights, news and events from Vicente LLP.
Nov 10, 2023
Federal and international law and policy insights, news and events from Vicente LLP.
By Meg Nash, Bridgette Nikisher
Nov 6, 2023
Maryland’s first adult-use licensing round is almost here! Do you have what you need? We’ve prepared a list to help guide you toward submission.The 30-day application period opens next week on November 13, 2023, at midnight ET and closes on December 12, 2023, at 5 p.m. ET.
By Jason Adelstone
Nov 6, 2023
While the cannabis industry in the United States awaits a marijuana scheduling decision from the DEA, many countries around the world continue to move forward with liberalizing their cannabis policies as a superior method of promoting the health and welfare of their citizens. In this blog post, we’ll take a closer look at five countries poised to make waves in the cannabis landscape in 2024, including Germany, Thailand, Colombia, the Czech Republic, and Switzerland.
By Meg Nash, Bridgette Nikisher
Nov 1, 2023
The clock is ticking—Maryland’s Social Equity Verification Portal will close on Tuesday, November 7. Have you completed your verification application? We recommend doing so as soon as possible to ensure that the Office of Social Equity has time to review your application and certify your social equity status.
By David Ullian
Oct 31, 2023
The Massachusetts Cannabis Control Commission’s amended regulations make substantial changes to the current regulatory framework related to HCAs, Social Equity businesses, municipal equity, and agent suitability. These changes reveal a clear intent to make real progress towards achieving the goals of creating new opportunities and a level playing field for Social Equity businesses, and continuing to build a successful, equitable cannabis industry in Massachusetts. Read this article for an overview of the key provisions in the amended regulations.
Commentary and analysis on cannabis, hemp, psychedelics, and other emerging therapies from the attorneys and policy specialists at the nation’s leading cannabis law firm.